The South African Pharmacy Council, Health Professions Council of South Africa and the South African Health Products Regulatory Authority (SAHPRA) have jointly cautioned the public, pharmacies and medical practitioners against any continued use, prescription or dispensing of iDEXIS Semaglutide, iDEXIS Tirzepatide, and iDEXIS Semaglutide/Tirzepatide
If no weight loss is seen after 6 weeks, it could be due to several factors like non-adherence to diet/lifestyle changes, underlying health issues, or the individual may not respond well to semaglutide treatment
You will self-inject the Semaglutide or Tirzepatide using a very small insulin-sized syringe/needle
We do not have additional information about any anti-doping investigations, and defer any further questions on the matter to USADA.
Reconstitution Support and Documentation Look for product-level notes on recommended solvent, storage, and stability